PARADIGM BIOCAPITAL ADVISORS LP Enanta Pharmaceuticals, Inc. Transaction History

PARADIGM BIOCAPITAL ADVISORS LP portfolio value:

$0
portfolio value

PARADIGM BIOCAPITAL ADVISORS LP quarter portfolio value change:

+9.73%
quarter

Enanta Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -148.21K shares -7.00M $51.87 0
Q2 2022 share Increase 0.00% 148.21K shares 7.00M $47.27 148.21K
Q1 2022 share Decrease -100.00% -75.50K shares -5.64M $71.18 0
Q4 2021 share Increase 0.00% 75.50K shares 5.64M $74.57 75.50K